Catalysts for Hikma Pharmaceuticals USA Inc
12 tracked
Mar 11, 2026
approval
LABETALOL HYDROCHLORIDE — FDA approval
Hikma Pharmaceuticals USA Inc
→
Feb 9, 2026
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→
Jan 15, 2025
recall
West-Ward Columbus Inc recall (Cls III)
Hikma Pharmaceuticals USA Inc
→
Nov 12, 2020
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→
Nov 12, 2020
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→
Nov 12, 2020
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→
Nov 12, 2020
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→
Feb 4, 2019
approval
LABETALOL HYDROCHLORIDE — FDA approval
Hikma Pharmaceuticals USA Inc
→
Apr 6, 2015
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→
Apr 6, 2015
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→
Apr 26, 2010
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→
Jul 20, 2009
approval
DIGOXIN — FDA approval
Hikma Pharmaceuticals USA Inc
→